Literature DB >> 7588916

Myocardial reperfusion injury: experimental evidence and clinical relevance.

P R Hansen1.   

Abstract

Critically timed reperfusion is a prerequisite for survival of ischaemic myocardium. However, reperfusion may have an injurious component, which in experimental models appears to be mediated by reperfusion-induced augmentation of the inflammatory response and generation of reactive oxygen free radicals. Four expressions of myocardial reperfusion injury have been defined, i.e. reperfusion arrhythmias, post-ischaemic contractile dysfunction (myocardial stunning), coronary vascular and microvascular reperfusion injury, and acceleration of necrosis in irreversibly injured cells/precipitation of necrosis in reversibly injured cells. Mechanical and pharmacological reperfusion therapy is well established in clinical cardiology, and this article reviews the experimental data underlying the current view of myocardial reperfusion injury, and considers the clinical relevance of this phenomenon.

Entities:  

Mesh:

Year:  1995        PMID: 7588916     DOI: 10.1093/oxfordjournals.eurheartj.a060991

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  19 in total

1.  Reperfusion Injury: Does It Exist and Does It Have Clinical Relevance?

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1997-01       Impact factor: 2.300

2.  Is "Lethal Reperfusion" an Oxymoron?

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1997-01       Impact factor: 2.300

3.  Effects of sevoflurane preconditioning and postconditioning on rat myocardial stunning in ischemic reperfusion injury.

Authors:  An-lu Dai; Li-hua Fan; Feng-jiang Zhang; Mei-juan Yang; Jing Yu; Jun-kuan Wang; Tao Fang; Gang Chen; Li-na Yu; Min Yan
Journal:  J Zhejiang Univ Sci B       Date:  2010-04       Impact factor: 3.066

Review 4.  Inflammation in acute coronary syndromes.

Authors:  N T Mulvihill; J B Foley
Journal:  Heart       Date:  2002-03       Impact factor: 5.994

5.  Ischemic preconditioning requires opening of pannexin-1/P2X(7) channels not only during preconditioning but again after index ischemia at full reperfusion.

Authors:  Donald A Vessey; Luyi Li; Michael Kelley
Journal:  Mol Cell Biochem       Date:  2011-01-26       Impact factor: 3.396

6.  Regional myocardial oxygen consumption estimated by carbon-11 acetate and positron emission tomography before and after repetitive ischemia.

Authors:  K F Kofoed; P R Hansen; S Holm; J D Hove; K Chen; W Jin; M Jensen; H Iida; B Hesse; J H Svendsen; H Kelbaek
Journal:  J Nucl Cardiol       Date:  2000 May-Jun       Impact factor: 5.952

7.  Release of pro-inflammatory mediators during myocardial ischemia/reperfusion in coronary artery bypass graft surgery.

Authors:  Madhulika Sharma; Nirmal Kumar Ganguly; Gaurav Chaturvedi; Shyam K S Thingnam; Siddhartha Majumdar; Rajendar Krishan Suri
Journal:  Mol Cell Biochem       Date:  2003-05       Impact factor: 3.396

8.  Combined sphingosine, S1P and ischemic postconditioning rescue the heart after protracted ischemia.

Authors:  Donald A Vessey; Luyi Li; Michael Kelley; Joel S Karliner
Journal:  Biochem Biophys Res Commun       Date:  2008-08-14       Impact factor: 3.575

9.  Valsartan preconditioning protects against myocardial ischemia-reperfusion injury through TLR4/NF-kappaB signaling pathway.

Authors:  Jian Yang; Hong Jiang; Jun Yang; Jia-Wang Ding; Li-Hua Chen; Song Li; Xiao-Dong Zhang
Journal:  Mol Cell Biochem       Date:  2009-04-16       Impact factor: 3.396

10.  Sphingosine 1-phosphate is an important endogenous cardioprotectant released by ischemic pre- and postconditioning.

Authors:  Donald A Vessey; Luyi Li; Norman Honbo; Joel S Karliner
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-07-31       Impact factor: 4.733

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.